Coloplast A/S (ETR:CBHD)

Market Cap	18.20B
Revenue (ttm)	3.73B
Net Income (ttm)	486.84M
Shares Out	n/a
EPS (ttm)	2.16
PE Ratio	37.39
Forward PE	23.57
Dividend	2.95 (3.65%)
Ex-Dividend Date	May 8, 2025

Volume	624
Average Volume	753
Open	82.30
Previous Close	81.96
Day's Range	79.00 - 82.30
52-Week Range	72.80 - 125.30
Beta	0.62
RSI	54.86
Earnings Date	Nov 4, 2025

About Coloplast

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1954
• Employees: 16,744
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: CBHD

Financial Performance

In 2025, Coloplast's revenue was 27.87 billion, an increase of 3.12% compared to the previous year's 27.03 billion. Earnings were 3.64 billion, a decrease of -28.03%.

Financial numbers in DKK